Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 10, 2024
Sen-Jam Pharmaceutical has entered a third strategic partnership with KVK-Tech. KVK-Tech is a Specialty Pharmaceutical Manufacturing company that will be providing formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam's first ...
read more
Wednesday, April 10, 2024
Univo IRB announced that Julie Blasingim has been promoted to CEO by Univo’s board of directors. As CEO, Blasingim will drive Univo IRB’s strategic growth and innovation, bringing a modern iteration of IRB solutions to unify patients and research, ...
read more
Wednesday, April 10, 2024
Syntegon announced the sale of its newly developed Versynta microBatch production cell to its first U.S. customer. Kindeva Drug Delivery will use Versynta microBatch to further expand its suite of aseptic fill-finish contract development and ...
read more
Wednesday, April 10, 2024
Myonex, a global clinical trial supply company, has completed the acquisition of SaveWay Compounding Pharmacy of Newark, Del. The pharmacy will operate as SaveWay Compounding Pharmacy, a Myonex company.
read more
Wednesday, April 10, 2024
Charles River Laboratories International, Inc. announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia Therapeutics Ltd. Charles River will manufacture High Quality (HQ) gene of interest plasmid to...
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good manufacturing practice (GMP) facility, process and analytical development capabilities, and ...
read more
SpineThera, Inc., a clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for epidural injection for the management of lumbar radicular pain) and ProMed Pharma ...
read more
Charles River Laboratories International, Inc. announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement. Ship of Theseus will leverage Charles River’s premier expertise to ...
read more
Almac Pharma Services announced the appointment of Terry Ernest as its new Director of Manufacturing Science and Technology.
read more
Stevanato Group S.p.A. announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
The addition of Ugo Gay underscores Stevanato Group’s unwavering commitment to driving operational efficiency, process standardization, and ...
read more
Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), announced a multi-year strategic partnership with Merck KGaA, Darmstadt, Germany, which operates its healthcare business as EMD Serono in the U.S. and Canada, to ...
read more
Wednesday, April 03, 2024
X-Chem, a provider of solutions for early-stage drug discovery, announced the addition of Dr. Erin Davis as chief technology officer.
read more
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, U.S., from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas.
read more
Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company. Both Bespak and Recipharm are backed by EQT Private Equity.
read more
Arch Biopartners Inc. announced that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
read more